ECOLAB INC.
ECLAPI behind this page
ECL FY 2025 request
Playground key active
/api/financials?ticker=ECL&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.
Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 16,081.2 | 15,741.4 | +2.2% |
Show Product Lines breakouts |
|||
| Product and equipment sales | 12,618.5 | 12,473.6 | +1.2% |
| Product and equipment sales · Global Institutional and Specialty | 4,950.4 | 5,000 | -1.0% |
| Product and equipment sales · Global Life Sciences | 709.4 | 664 | +6.8% |
| Product and equipment sales · Global Water | 6,958.7 | 6,809.6 | +2.2% |
| Service and lease sales | 3,462.7 | 3,267.8 | +6.0% |
| Service and lease sales · Global Institutional and Specialty | 1,154.2 | 1,103.4 | +4.6% |
| Service and lease sales · Global Life Sciences | 38.5 | 35.3 | +9.1% |
| Service and lease sales · Global Pest Elimination | 1,246.3 | 1,162.8 | +7.2% |
| Service and lease sales · Global Water | 1,023.7 | 966.3 | +5.9% |
Show Business Segments breakouts |
|||
| Global Institutional and Specialty | 6,104.6 | 6,103.4 | 0.0% |
| Global Institutional and Specialty · Asia Pacific | 329.2 | 322.4 | +2.1% |
| Global Institutional and Specialty · CA | 250.3 | 254.1 | -1.5% |
| Global Institutional and Specialty · CN | 198.1 | 182.7 | +8.4% |
| Global Institutional and Specialty · Europe | 1,026.1 | 1,037.5 | -1.1% |
| Global Institutional and Specialty · India, Middle East and Africa | 99.1 | 105.1 | -5.7% |
| Global Institutional and Specialty · Latin America | 205.8 | 209.6 | -1.8% |
| Global Institutional and Specialty · Operating Segments | 5,962 | 5,979.4 | -0.3% |
| Global Institutional and Specialty · US | 3,996 | 3,992 | +0.1% |
| Global Life Sciences | 747.9 | 699.3 | +6.9% |
| Global Life Sciences · Asia Pacific | 54.5 | 37.2 | +46.5% |
| Global Life Sciences · CA | 4 | 2.8 | +42.9% |
| Global Life Sciences · CN | 52.6 | 54.1 | -2.8% |
| Global Life Sciences · Europe | 382.4 | 374.4 | +2.1% |
| Global Life Sciences · India, Middle East and Africa | 31 | 22.4 | +38.4% |
| Global Life Sciences · Latin America | 18.3 | 21.1 | -13.3% |
| Global Life Sciences · Operating Segments | 706.1 | 670.5 | +5.3% |
| Global Life Sciences · US | 205.1 | 187.3 | +9.5% |
| Global Pest Elimination | 1,246.3 | 1,162.8 | +7.2% |
| Global Pest Elimination · Asia Pacific | 35.1 | 32.1 | +9.3% |
| Global Pest Elimination · CA | 12.8 | 11.8 | +8.5% |
| Global Pest Elimination · CN | 61.3 | 60 | +2.2% |
| Global Pest Elimination · Europe | 205.7 | 187.5 | +9.7% |
| Global Pest Elimination · India, Middle East and Africa | 7 | 7.1 | -1.4% |
| Global Pest Elimination · Latin America | 60.4 | 58.7 | +2.9% |
| Global Pest Elimination · Operating Segments | 1,219.2 | 1,140.1 | +6.9% |
| Global Pest Elimination · US | 864 | 805.6 | +7.2% |
| Global Water | 7,982.4 | 7,775.9 | +2.7% |
| Global Water · Asia Pacific | 945.7 | 947.6 | -0.2% |
| Global Water · CA | 232.3 | 224 | +3.7% |
| Global Water · CN | 410.4 | 400.4 | +2.5% |
| Global Water · Europe | 1,661.1 | 1,593.7 | +4.2% |
| Global Water · India, Middle East and Africa | 501.1 | 493 | +1.6% |
| Global Water · Latin America | 816.7 | 810.5 | +0.8% |
| Global Water · Operating Segments | 7,679.9 | 7,483.4 | +2.6% |
| Global Water · US | 3,415.1 | 3,306.7 | +3.3% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 514 | 468 | +9.8% |
| Operating Segments | 15,567.2 | 15,273.4 | +1.9% |
| Cost of Revenue | 8,930.8 | 8,899.7 | +0.3% |
Show Product Lines breakouts |
|||
| Product and equipment sales | 6,955.8 | 6,990 | -0.5% |
| Service and lease sales | 1,975 | 1,909.7 | +3.4% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 7.7 | 5.2 | +48.1% |
| Global Institutional and Specialty · Operating Segments | 2,977.7 | 3,131 | -4.9% |
| Global Life Sciences · Operating Segments | 382.6 | 382.6 | 0.0% |
| Global Pest Elimination · Operating Segments | 686.3 | 639.8 | +7.3% |
| Global Water · Operating Segments | 4,585.9 | 4,470.9 | +2.6% |
Show Equity Components breakouts |
|||
| Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges · Reclassification Out Of Accumulated Other Comprehensive Income | 4.4 | 4 | +10.0% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 8,640.2 | 8,629.5 | +0.1% |
| Selling, General & Administrative | 4,257.9 | 4,228.2 | +0.7% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 195.2 | 195.6 | -0.2% |
| Global Institutional and Specialty · Operating Segments | 1,626.5 | 1,646.2 | -1.2% |
| Global Life Sciences · Operating Segments | 202.8 | 196.1 | +3.4% |
| Global Pest Elimination · Operating Segments | 295.8 | 290.6 | +1.8% |
| Global Water · Operating Segments | 1,830.1 | 1,805.3 | +1.4% |
Show Equity Components breakouts |
|||
| Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges · Reclassification Out Of Accumulated Other Comprehensive Income | 0.5 | 5.8 | -91.4% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 4,150.4 | 4,133.8 | +0.4% |
| Other Nonrecurring Income Expense | 154.9 | -188.9 | +182.0% |
Show Product Lines breakouts |
|||
| Product and equipment, and service and lease · Cost Of Sales | 7.7 | 5.3 | +45.3% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 150.3 | -188.7 | +179.7% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 150.3 | -188.7 | +179.7% |
Show Income Statement Location breakouts |
|||
| Cost Of Sales | 7.7 | 5.3 | +45.3% |
| Special (gains) and charges | 154.9 | -188.9 | +182.0% |
| Operating Income | 2,737.6 | 2,802.4 | -2.3% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | -353.2 | -12.1 | -2819.0% |
| Global Institutional and Specialty · Operating Segments | 1,357.8 | 1,202.2 | +12.9% |
| Global Life Sciences · Operating Segments | 120.7 | 91.8 | +31.5% |
| Global Pest Elimination · Operating Segments | 237.1 | 209.7 | +13.1% |
| Global Water · Operating Segments | 1,263.9 | 1,207.2 | +4.7% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 111.3 | 103.6 | +7.4% |
| Operating Segments | 2,626.3 | 2,698.8 | -2.7% |
| Non-Operating Income (Expense) | -51.4 | -51.3 | -0.2% |
| Interest Expense Net | 241.1 | 282.5 | -14.7% |
Show Equity Components breakouts |
|||
| Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges · Reclassification Out Of Accumulated Other Comprehensive Income | -1.5 | -1.9 | +21.1% |
| Income Before Taxes | 2,547.9 | 2,571.2 | -0.9% |
| Income Tax Expense (Benefit) | 454.6 | 439.3 | +3.5% |
| Net Income | 2,093.3 | 2,131.9 | -1.8% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 17.7 | 19.5 | -9.2% |
| Parent | 2,075.6 | 2,112.4 | -1.7% |
| Retained Earnings | 2,075.6 | 2,112.4 | -1.7% |
| Net Income Loss Attributable To Noncontrolling Interest | 17.7 | 19.5 | -9.2% |
| Net Income | 2,075.6 | 2,112.4 | -1.7% |
| EPS (Basic) | 7.33 | 7.43 | -1.3% |
| EPS (Diluted) | 7.28 | 7.37 | -1.2% |
| Wtd Avg Shares (Basic) | 283.3 | 284.3 | -0.4% |
| Wtd Avg Shares (Diluted) | 285.2 | 286.6 | -0.5% |
| Research & Development | 202 | 207 | -2.4% |
| Interest Income | -65.1 | -57.8 | -12.6% |
| Comprehensive Income | 2,183.3 | 1,980.8 | +10.2% |
| Professional Fees (FY) | — | — | — |
Show Disposal Group Classification breakouts |
|||
| Disposal Group Disposed Of By Sale Not Discontinued Operations · Global surgical solutions business | 3 | 15.6 | -80.8% |
| Disposal Group Heldforsale Not Discontinued Operations · Global surgical solutions business | 3 | — | — |
Show Income Statement Location breakouts |
|||
| Special (gains) and charges · One Ecolab Initiative Program | 30.9 | 23.7 | +30.4% |
| Interest Expense | 306.2 | 340.3 | -10.0% |
| Operating Lease Lease Income | 562.1 | 534.9 | +5.1% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 646.2 | 1,256.8 | -48.6% |
| Accounts Receivable | 3,249.4 | 2,865 | +13.4% |
| Inventory | 1,490.4 | 1,464.9 | +1.7% |
| Other Assets Current | 569.6 | 439 | +29.7% |
| Total Current Assets | 5,955.6 | 6,025.7 | -1.2% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 4,276.6 | 3,752.4 | +14.0% |
| Goodwill | 9,227 | 7,907.3 | +16.7% |
Show Business Segments breakouts |
|||
| Global Institutional and Specialty | 1,041.5 | 1,024.3 | +1.7% |
| Global Life Sciences | 2,490.4 | 2,408.7 | +3.4% |
| Global Pest Elimination | 189.6 | 169.4 | +11.9% |
| Global Water | 5,505.5 | 4,304.9 | +27.9% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | 17.4 | 156.7 | -88.9% |
| Operating Lease Right-of-Use Assets | 765.9 | 723.2 | +5.9% |
| Other Non-Current Assets | 782.7 | 670.4 | +16.8% |
| Total Assets | 24,696.3 | 22,387.8 | +10.3% |
| Intangible Assets | 2,458.5 | 2,078.8 | +18.3% |
| Deferred Tax Assets | 181 | 155.5 | +16.4% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 3,688.5 | 3,308.8 | +11.5% |
| Current Liabilities | |||
| Debt Current | 870.4 | 615.7 | +41.4% |
| Accounts Payable | 2,071 | 1,810 | +14.4% |
| Employee Related Liabilities Current | 721.5 | 727.4 | -0.8% |
| Accrued Income Taxes Current | 134.3 | 127 | +5.7% |
| Other Liabilities Current | 1,737.5 | 1,512.7 | +14.9% |
| Total Current Liabilities | 5,534.7 | 4,792.8 | +15.5% |
| Commercial Paper (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| U.S. commercial paper program | 100 | — | — |
| Non-Current Liabilities | |||
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 546.1 | 634.9 | -14.0% |
Show Retirement Plan Type breakouts |
|||
| Defined Benefit Postretirement Health Coverage · US | 90.7 | 91.5 | -0.9% |
| Pension Plans Defined Benefit · Foreign Plan | 383.7 | 370.5 | +3.6% |
| Pension Plans Defined Benefit · US | 66.9 | 142.8 | -53.2% |
| Deferred Tax Liabilities | 329.9 | 280 | +17.8% |
| Other Non-Current Liabilities | 518.7 | 366.2 | +41.6% |
| Total Liabilities | 14,891.8 | 13,598.6 | +9.5% |
| Other Liabilities | |||
| Long Term Debt And Capital Lease Obligations | 7,365.9 | 6,949.2 | +6.0% |
| Operating Lease Liability Noncurrent Excluded From Long Term Debt | 596.5 | 575.5 | +3.6% |
| Stockholders' Equity | |||
| Common Stock | 369.4 | 367.8 | +0.4% |
| Additional Paid In Capital Common Stock | 7,521.3 | 7,159.6 | +5.1% |
| Retained Earnings | 12,834 | 11,517.1 | +11.4% |
| Accumulated Other Comprehensive Income | -1,874.3 | -1,982 | +5.4% |
| Treasury Stock Value | -9,079.6 | -8,305.2 | -9.3% |
| Total Stockholders' Equity | 9,770.8 | 8,757.3 | +11.6% |
| Minority Interest | 33.7 | 31.9 | +5.6% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 9,804.5 | 8,789.2 | +11.6% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -1,874.3 | -1,982 | +5.4% |
| Additional Paid In Capital | 7,521.3 | 7,159.6 | +5.1% |
| Common Stock | 369.4 | 367.8 | +0.4% |
| Noncontrolling Interest | 33.7 | 31.9 | +5.6% |
| Parent | 9,770.8 | 8,757.3 | +11.6% |
| Retained Earnings | 12,834 | 11,517.1 | +11.4% |
| Treasury Stock Common | -9,079.6 | -8,305.2 | -9.3% |
| Total Liabilities & Equity | 24,696.3 | 22,387.8 | +10.3% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation | 672.6 | 634.9 | +5.9% |
| Adjustment For Amortization | 303.8 | 300.5 | +1.1% |
| Deferred Income Taxes And Tax Credits | -33.4 | -190.5 | +82.5% |
| Stock-Based Compensation | 136.6 | 134.8 | +1.3% |
| Pension And Other Postretirement Benefit Contributions | -77.8 | -54.4 | -43.0% |
| Pension And Other Postretirement Benefit Expense | 15 | 14.3 | +4.9% |
| Restructuring Costs | 18.8 | 23.7 | -20.7% |
| Gain Loss On Sale Of Business | 1.1 | -381.7 | +100.3% |
| Other Non-Cash Items | 28.8 | 24.3 | +18.5% |
| Change in Accounts Receivable | -185.9 | -146.7 | -26.7% |
| Change in Inventory | 36.4 | -115.6 | +131.5% |
| Increase Decrease In Other Operating Assets | 83.6 | -24.3 | +444.0% |
| Change in Accounts Payable | 67.7 | 300 | -77.4% |
| Increase Decrease In Other Operating Liabilities | -208 | 162.7 | -227.8% |
| Net Cash from Operations | 2,952.6 | 2,813.9 | +4.9% |
| Deferred Income Taxes | -36.2 | -184.6 | +80.4% |
| Investing Activities | |||
| Capital Expenditures | -1,048.3 | -994.5 | -5.4% |
| Proceeds From Sale Of Productive Assets | 52.3 | 11.3 | +362.8% |
| Payments To Acquire Businesses And Interest In Affiliates | -1,621.3 | -312.9 | -418.2% |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | -14.9 | 889.7 | -101.7% |
| Other Investing Activities | -75 | -27.4 | -173.7% |
| Net Cash from Investing | -2,707.2 | -433.8 | -524.1% |
| Financing Activities | |||
| Proceeds From Repayments Of Short Term Debt | 98.2 | 1.9 | +5068.4% |
| Proceeds From Issuance Of Long Term Debt | 1,045.6 | — | — |
| Repayments Of Long Term Debt | -674.2 | -630.4 | -6.9% |
| Share Repurchases | -783.8 | -986.5 | +20.5% |
| Payments Of Dividends Common Stock | -753.6 | -664.3 | -13.4% |
| Proceeds From Stock Options Exercised | 228.2 | 259.4 | -12.0% |
| Proceeds From Payments For Other Financing Activities | -13.7 | -3.6 | -280.6% |
| Net Cash from Financing | -853.3 | -2,024.1 | +57.8% |
| Supplemental | |||
| Income Taxes Paid | 548.1 | 647.4 | -15.3% |
| Interest Paid | 302.6 | 342.6 | -11.7% |
| Income Taxes Paid | 548.1 | 647.4 | -15.3% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -2.7 | -18.7 | +85.6% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations | -610.6 | 337.3 | -281.0% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 646.2 | 1,256.8 | -48.6% |
Values in millions USD. Source: SEC EDGAR 10-K filing.